LBF20307PG39: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName= (5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |SysName= (5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | ||
|Common Name=&&15-epi-prostaglandin A_2&&(5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid&& | |Common Name=&&15-epi-prostaglandin A_2&&(5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid&& | ||
|IR Spectra=nu^f_m _a _x 1350 and 970cm^- ^1 [[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]] | |IR Spectra= nu ^f_m _a _x 1350 and 970cm^- ^1 [[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]] | ||
|NMR Spectra=^1 H- | |NMR Spectra=^1 H-NMR delta ppm5.41, 5.58.[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]] | ||
|Source=15-Epi-prostaglandin A _2 and its acetate methyl ester were isolated from Caribbean Gorgonian, Plexaura homomalla.[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]] | |Source=15-Epi-prostaglandin A _2 and its acetate methyl ester were isolated from Caribbean Gorgonian, Plexaura homomalla.[[Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185|{{RelationTable/GetFirstAuthor|Reference:Weinheimer_AJ:Spraggins_RL:,Tetrahedron Lett.,1969,59,5185}}]] | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Revision as of 14:00, 19 February 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR8046 |
| LipidMaps | LMFA03010092 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20307PG39 |
| 15-epi-prostaglandin A2 | |
|---|---|
| |
| Structural Information | |
| (5Z, 13E) - (8R,12S,15R) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |
| |
| (15R)-PGA_2 | |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
| Physicochemical Information | |
| 15-Epi-prostaglandin A _2 and its acetate methyl ester were isolated from Caribbean Gorgonian, Plexaura homomalla. Weinheimer_AJ et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | ν f m ax1350 and 970cm-1 Weinheimer_AJ et al. |
| NMR Spectra | 1H-NMR δ ppm5.41, 5.58. Weinheimer_AJ et al. |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
